CapsoVision (NASDAQ:CV) Shares Gap Down – What’s Next?

Shares of CapsoVision, Inc. (NASDAQ:CV) gapped down prior to trading on Friday . The stock had previously closed at $12.39, but opened at $10.85. CapsoVision shares last traded at $11.05, with a volume of 7,782 shares trading hands.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on CV shares. Roth Capital set a $7.00 price target on shares of CapsoVision in a research report on Tuesday, November 4th. Benchmark reiterated a “speculative buy” rating on shares of CapsoVision in a report on Friday, November 14th. Weiss Ratings reissued a “sell (e)” rating on shares of CapsoVision in a research report on Monday, December 29th. Finally, Zacks Research upgraded CapsoVision to a “hold” rating in a research note on Wednesday, November 5th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $6.00.

CapsoVision Stock Performance

The business’s fifty day moving average is $7.97.

CapsoVision (NASDAQ:CV) last released its quarterly earnings results on Thursday, November 13th. The company reported ($0.17) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.03). The firm had revenue of $3.54 million during the quarter.

Hedge Funds Weigh In On CapsoVision

An institutional investor recently bought a new position in CapsoVision stock. New York State Common Retirement Fund purchased a new position in shares of CapsoVision, Inc. (NASDAQ:CV) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 7,114 shares of the company’s stock, valued at approximately $34,000.

CapsoVision Company Profile

CapsoVision, Inc (NASDAQ: CV) is a medical device company specializing in advanced capsule endoscopy systems for gastrointestinal diagnostics. The company’s flagship product, the CapsoCam® Plus System, features a swallowable, tether-free capsule equipped with four side-viewing cameras that capture high-resolution, 360-degree images of the small intestine. By storing images internally rather than transmitting data wirelessly, CapsoCam Plus enables patients to maintain normal daily activities during the procedure and reduces the risk of signal loss or image drop-out.

In addition to its capsule hardware, CapsoVision offers CapsoCloud®, a secure, cloud-based platform that streamlines image retrieval, storage and reporting.